Yasuo Hamamoto

Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Yoon‐Koo Kang, Narikazu Boku, Taroh Satoh et al. · The Lancet · 2017 · 2.2K citations · Full text

Esophageal Cancer, Gastrointestinal Oncology, Least Two +8

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Ken Kato, Byoung Chul Cho, Masanobu Takahashi et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Esophageal Cancer, Gastrointestinal Oncology, Medicine +7

Appearance of enhanced tissue features in narrow-band endoscopic imaging

Kazuhiro Gono, Takashi Obi, Masahiro Yamaguchi et al. · Journal of Biomedical Optics · 2004 · 915 citations · Full text

Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial

Shuichi Hironaka, Shinya Ueda, Hirofumi Yasui et al. · Journal of Clinical Oncology · 2013 · 548 citations

Narrow-Band Imaging in the Diagnosis of Colorectal Mucosal Lesions: A Pilot Study

Hirohisa Machida, Yasushi Sano, Yasuo Hamamoto et al. · Endoscopy · 2004 · 518 citations